Follow us...

 

Search News Archives

News Channels

 

Coronavirus (COVID-19)

 

 

View Channel

New Laboratory Products

 

View Channel

Lab News

 

View Channel

Research & Case Studies

 

View Channel

Microscopy | Image Analysis

 

View Channel

Separation Science

 

View Channel

Videos

 

View Channel

Events | Webinars

 

View Channel

Conferences | Events

Sterling Pharma Solutions launches £11 million Material Science Centre

publication date: Oct 2, 2020
 | 
author/source: Sterling Pharma Solutions

sterling-pharma-solutions-launches-11-million-material


Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has officially opened its new multi-million-pound Material Science Centre (MSC), after announcing the investment last year.

The three-floor MSC comprises six ISO Class 8 cleanrooms, which house four milling and micronisation suites. The new facility, which is the latest step in the company’s continued growth plans, also contains warehousing and workshop facilities dedicated to the milling operations, as well as a new fully equipped solid state laboratory and an analytical services laboratory and write up area.

Kevin Cook, Chief Executive Officer at Sterling, said: “The centre will provide a range of specialist solid state chemistry and milling services to complement the services we already provide to our customer base.

“This investment is in direct response to customer requirements to bring our solid form services, which have previously been outsourced to third parties, in-house. The centre will allow us to manage more of the product processing and as a result improve efficiencies; mitigating risk and allowing us to provide our customers with more cost-effective solutions. It will also help to reduce overall manufacturing time as we continue to develop more efficient processes.”

Sterling Pharma Solutions’ solid form development team will be housed within the facility and will work to optimise existing processes across four connected areas of solid form investigation including, salt/cocrystal screening, polymorph screening, pre-formulation evaluation and crystallisation development.

As a result of the ongoing pandemic and visitor restrictions, Sterling will be launching the centre virtually. This will include a webinar hosted by Sterling’s experts to introduce the facility, team and services.

A virtual tour of the facility will also be released next month to allow external stakeholders to take a closer look at the new facility, remotely and safely.

 

Learn more about the new facility

 

About Sterling Pharma Solutions

Sterling Pharma Solutions, which has sites in the UK and the US, is a well-established developer and manufacturer of pharmaceutical APIs. Specialising in hazardous chemistry and handling controlled substances, the company is dedicated to continuously developing innovative solutions to customer challenges, such as handling potent molecules and increasing operational effectiveness.

The US facility, located close to Research Triangle Park, supports the development and manufacturing requirements for pre-clinical and early phase clinical supply for volumes from millilitres up to 100 litre batches. The team has expertise in medicinal chemistry services, including lead optimisation and parallel synthesis, cGMP analytical services to support testing and release, process development and small-scale API manufacturing.


 



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 

 

 

Media Partners